In in vitro assays, the AURKA inhibitor MLN8237 inhibited the growth of both IM-sensitive and IM-resistant GIST cells in a concentration-dependent manner and exerted synergistic cytotoxicity with IM. This evidence concerns the gene AURKA and gastrointestinal stromal tumor.